期刊文献+

宫颈脱落细胞人乳头状瘤病毒基因分型检测在宫颈癌筛查及宫颈上皮内瘤样病变宫颈环形电切术后随访中的意义 被引量:18

Clinical Analysis of Cervical Cytology HPV Subtyping Tests and the Significance in CIN Follow up after Cervical Loop Electrosurgical Excision
下载PDF
导出
摘要 目的探讨宫颈脱落细胞人乳头状瘤病毒(HPV)亚型(C-HPV-S)在宫颈癌早期诊断和宫颈上皮内瘤样病变(CIN)宫颈环形电切术(LEEP)后随访中的价值。方法选择2008年1月~2011年9月在济南军区总医院检查C-HPV-S的6695例患者,包括查体者1339例(体检组)和因患妇科疾病就诊者5356例(患者组),受检者均行宫颈薄层液基细胞学检查(TCT)并采用导流杂交基因芯片技术行C-HPV-S检测。对其中病理诊断为CIN者行LEEP,术后6个月、1~2年随访时行TCT和C-HPV-S检查。结果①体检组和患者组HPV感染率分别为17.8%和26.0%,差异有统计学意义(P<0.05)。对体检组和患者组宫颈柱状上皮异位(CCE)、其他宫颈炎、宫颈尖锐湿疣、CINⅠ-Ⅱ、CINⅢ及宫颈癌同类疾病HPV感染率分别比较,差异均无统计学意义(P>0.05)。②HPV及HR-HPV感染率随宫颈病变病理级别的增高(宫颈炎→CINⅠ-Ⅱ→CINⅢ→宫颈癌)而增高,且单一感染率增高,多重感染率无明显变化。CINⅠ-Ⅱ、CINⅢ和宫颈癌HPV及HR-HPV感染率、单一HPV感染率均显著高于宫颈炎,差异有统计学意义(P<0.05)。③对CIN患者LEEP后1~2年随访,CINⅠ-Ⅱ组复发率为1.2%(4/335),HPV持续感染率为3.9%(13/274);CINⅢ组复发率为4.4%(6/137),HPV持续感染率为9.5%(13/124)。两组复发率与HPV持续感染率差异均有统计学意义(P<0.05)。结论 C-HPV-S有助于早期发现和预测CIN,也可作为CIN术后随访的重要指标,为预防宫颈癌的发生提供干预依据。 Objective To investigate the value of the cervical cytology HPV subtypes(C-HPV-S) in early diagnosis of cervical cancer and follow up of cervical loop electrosurgical excision procedure(LEEP) in cervical intraepithelial neoplasia(CIN).Methods From January 2008 to September 2011,6695 patients who were checked C-HPV-S in Jinan Military General Hospital,including 1339 patients in the physical examination group(PE group) and 5356 patients in the patient group(P group).All subjects underwent cervical thinprep cytologic test(TCT) and the HPV subtypes were detected by flow-through hybridization gene chip technology.Pathological analysis was used for confirmation.491 patients with CIN underwent LEEP.HPV and TCT were tested again on month 6,12 and 24 after LEEP during the follow-up stage.Results ①The C-HPV-S infection rate in PE group and P group(both groups containing patients with CCE,CIN and cervical cancer) were 17.8% and 26.0%(P0.05),respectively.The C-HPV-S infection rate showed no statistical difference in same disease in both PE group and P group(P0.05).②The C-HPV-S infection rate rised along with the increasing pathological abnormalities from cervicitis→CIN Ⅰ-Ⅱ→CIN Ⅲ→cervical cancer.The single type infection rate increased along with the pathological degree rising;however,the rates of multiple HPV subtypes infection did not increase.③The recurrence rate of CIN Ⅰ-Ⅱ was 1.1%(4/354) and the HPV persistent infection rate was 4.5%(13/286).The recurrence rate of CIN 1 Ⅱ was 4.4%(6/137) and the HPV persistent infection was 10.5%(13/124) in CIN Ⅲ after LEEP during 1 to 2 years follow-up stage.The recurrence and HPV persistent infection rates were statistically different from CIN Ⅰ-Ⅱ to CIN Ⅲ groups(P0.05).Conclusion The detection of C-HPV-S is valuable not only to early diagnose and forecast CIN,but also to indicate the prognosis of CIN,which can provide intervention basis for prevention of cervical cancer.
出处 《解放军医药杂志》 CAS 2012年第3期14-17,共4页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
基金 2007年国家卫生部基金课题(WKJ2007-3-0001)
关键词 乳头状瘤病毒 基因分型 宫颈肿瘤 宫颈上皮内瘤样病变 随访研究 Papillomavirus human Genotyping Cervix neoplasms Cervical intraepithelial neoplasia Follow-up studies
  • 相关文献

参考文献12

  • 1Cai H B,Ding X H,Chen C C.Prevalence of single andmultiple human papillomavirus types in cervical cancerand precursor lesions in Hubei,China[J].Oncology,2009,76(3):157-161.
  • 2伍星蓉,朱威,张海萍,连石.400例健康体检妇女宫颈感染人乳头瘤状病毒基因亚型的检测及分析[J].首都医科大学学报,2009,30(4):560-562. 被引量:36
  • 3李隆玉,乔志强.宫颈癌前病变患者治疗前后HPV病毒负荷量变化的临床分析[J].中华肿瘤防治杂志,2006,13(4):298-300. 被引量:24
  • 4Munoz N,Bosch F X,de Sanjose S,et al.EpidemiologicClassification of human papillomavirus types associatedwith cervical cancer[J].N Engl J Med,2003,348(6):518-527.
  • 5Cogliano V,Baan R,Straif K,et al.Carcinogenicity ofHuman papillomavirus[J].The Lancet Oncol,2005,6(4):204.
  • 6Walboomers J M,Jacobs M V,Manos M M,et al.Human papillomavirus is a necessary cause of invasivecervical cancer worldwide[J].J Pathol,1999,189(1):12-19.
  • 7尹格平,李娟,朱彤宇,黄海士,赵晓利,赵秀娥,何君梅.荧光原位杂交技术检测宫颈上皮内瘤变和宫颈癌细胞hTERC基因扩增的研究[J].中国实用妇科与产科杂志,2010,26(3):201-204. 被引量:10
  • 8Lorincz A T,Castle P E,Sherman M E.Viral load of hu-man papilloma virus and risk of CIN3 or cervical cancer[J].The Lancet,2002,360(9328):228-229.
  • 9NCCN Clinical Practice Guidelinesin Oncology.Cervicalcancer screening[EB/OL].[2010-11-18].http://www.nccn.org.
  • 10An H J,Cho N H,Lee S Y,et al.Correlaton of cervicalcarcionma and precancerous lesions with human papillo-mavirus(HPV)genetypes detected with theHPV DNAchip microarray mithod[J].Cancer,2003,97(7):1672-1680.

二级参考文献25

  • 1黎静,钟梅.关于卵巢癌遗传学研究技术新进展[J].医学综述,2006,12(23):1440-1442. 被引量:8
  • 2张业贵,毕新刚,韩亚玲,蔡岩,徐昕,吴玉鹏,杨壹羚,马建辉,赵平,贾雪梅,王明荣.多色荧光原位杂交在膀胱尿路上皮癌诊断中的应用[J].癌症,2007,26(2):189-193. 被引量:27
  • 3Bosch F X, de Sanjose S. Chapter 1 : Human papillomavirus and cervical cancer-burden and assessment of causality [J]. J Natl Cancer Inst Monogr, 2003,31:3-13.
  • 4Walboomers J M M, Jacobs M V, Manos M M, et al. Human papillomavirus is a necessary cause of invasive cervical cancer world wide[J]. J Pathol, 1999,189:12-19.
  • 5Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [ J]. CA Cancer J Clin, 2005,55:74-108.
  • 6Bosch F X, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer [ J ]. J Clin Pathol, 2002,55 : 244-265.
  • 7Brown D R, Shew M L, Qadadri B, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women [ J ]. J Infect Dis, 2005,191 : 182-192.
  • 8Parkin D M. The global health burden of infection - associated cancers in the year 2002 [J]. Int J Cancer, 2006, 118:3030-3044.
  • 9Dunne E F, Unger E R, Steinberg M, et al. Prevalence of HPV infection among females in the United States [ J ]. JAMM, 2007,297:813-819.
  • 10Del Prete R, Di Taranto A M, Lipsi M R, et al. Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy [ J ]. J Clin Virol, 2008, 42:211-214.

共引文献67

同被引文献175

引证文献18

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部